We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 90 days · 90 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 90 days • 1 price levels
Price Analysis
Most common price: £490 (90 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 90 days
Description
Key Features
Provides latent demand estimates in millions of U.S. dollars for HER-2 positive breast cancer chemotherapy.
Covers 10,833 specific US zip codes to offer localized market data for industry analysis.
Includes percent share data for each zip code relative to its state and the entire United States.
Offers comparative benchmarks to help gauge the value of one zip code against others.
Serves as a statistical resource for improving distribution and sales force planning.
Product Specifications
- Format
- paperback
- ASIN
- B0BSWFSM5Q
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
Breast Cancer Diagnostic Products Outlook 2023-2028 Report
2023-2028 US Breast Cancer Screening Outlook by Zip Code
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
Price unavailable
The 2023-2028 Outlook for Breast Cancer Screenings in China
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
Price unavailable
The 2025-2030 World Outlook for Breast Cancer Screenings
Price unavailable
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City